SAS

AstraZeneca, SAS Team up on AI and Analytics in Clinical Trials

AI and analytics software company SAS is collaborating with global biopharmaceutical company AstraZeneca to increase efficiency and drive automation in the delivery of statistical analyses for clinical and post-approval submissions to regulatory authorities.

DuPont Says $6.4 Billion Danisco Takeover In The Bag

Impact of Volcanic Ash Cloud on Europe